In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Catherine Longworth

Catherine Longworth is a reporter covering commercial and R&D developments in the medtech industry. A graduate of St. George's, University of London, Catherine holds a BSc in Biomedical Science. Before joining Informa, she worked in the editorial team at Pharmaceutical Press, the publishing division of the Royal Pharmaceutical Society, where she wrote and edited for a number of pharmaceutical publications. After gaining experience in the world of scientific publishing, Catherine took the leap to study a postgraduate qualification in journalism. During the course, she carried out placements with local London newspapers, writing general news and building her portfolio by reporting on a wide range of current affairs such as the European migrant crisis, political protests and the London mayoral election. Catherine is passionate about human rights and is fascinated by the innovative nature of the medtech industry and the healthcare advances that have the greatest benefit to mankind. She lives in London and loves music, arts, travel, writing, reading and is always happy to receive recommendations for books or places to travel!

Latest From Catherine Longworth

Industry Impact: Siemens Healthineers $16.4Bn Acquisition Of Varian – What Next?

Siemens Healthineers' acquisition of radiation oncology company Varian Medical Systems creates an oncology giant. Analysts disagree on whether its the right move for the companies.

M & A Business Strategies

Conformal Medical Raises $85M To Advance Its Left Atrial Appendage Closure Device

The series C financing will support development of its CLAAS device, an alternative to anticoagulant drugs for atrial fibrillation patients.

Cardiology Financing

Investor Eye: Claudio D’Angelo Of RYSE Asset Management Explains Early-Stage Digital Health Investment

RYSE head tells Medtech Insight about his firm’s shift to investing in virtual primary care and telemedicine.

Investor Eye Digital Health

COVID-19 Continues To Drive Demand For Baxter’s Acute Therapies Portfolio

Demand for Baxter's acute therapy products helped offset declines across its advanced surgery, pharmaceuticals and medication-delivery businesses in the second quarter.

Coronavirus COVID-19 Sales & Earnings

Investors Pump $257M Into Thrive’s Liquid Biopsy Test

Thrive is developing CancerSEEK, a liquid biopsy test designed to detect cancers at earlier stages of disease.

Cancer Cancer

Exec Chat: Kees Wesdorp Leads Philips' Advancement Of Precision Diagnosis During COVID-19

Kees Wesdorp, the leader of Philips' Precision Diagnosis business cluster told Medtech Insight how the division is delivering on digital solutions, beyond acute care, to drive a response to the COVID-19 pandemic

Exec Chat Business Strategies
See All
UsernamePublicRestriction

Register